within Pharmacolibrary.Drugs.ATC.N;

model N06AA17
  extends Pharmacokinetic.Models.PK_2C_enteral(
    weight         = 70,
    F              = 0.3,
    Cl             = 0.0002,
    adminDuration  = 600,
    adminMass      = 100 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.007,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.005333333333333333,
    Tlag           = 720,            
    Vdp             = 0.006,
    k12             = 25,
    k21             = 25
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>N06AA17</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Amoxapine is a tricyclic antidepressant (TCA) used in the treatment of major depressive disorder. It acts primarily by inhibiting the reuptake of norepinephrine and serotonin. Amoxapine was approved for use in depression, but its use has declined due to the development of newer antidepressants and concerns about side effects.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters for healthy adult volunteers; majority studies report oral administration in standard therapeutic doses.</p><h4>References</h4><ol><li><p>Calvo, B, et al., &amp; Domínguez-Gil, A (1985). Pharmacokinetics of amoxapine and its active metabolites. <i>International journal of clinical pharmacology, therapy, and toxicology</i> 23(4) 180–185. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/3997304/\">https://pubmed.ncbi.nlm.nih.gov/3997304</a></p></li><li><p>Pawar, SD, et al., &amp; Kumar, P (2023). Amoxapine-Loaded Solid Lipid Nanoparticles with Superior Preclinical Pharmacokinetics for Better Brain Delivery: LC-MS/MS and GC-MS Analysis. <i>ACS chemical neuroscience</i> None –. DOI:<a href=\"https://doi.org/10.1021/acschemneuro.2c00673\">10.1021/acschemneuro.2c00673</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/37027804/\">https://pubmed.ncbi.nlm.nih.gov/37027804</a></p></li><li><p>Wong, YC, et al., &amp; Zuo, Z (2012). Investigation of the disposition of loxapine, amoxapine and their hydroxylated metabolites in different brain regions, CSF and plasma of rat by LC-MS/MS. <i>Journal of pharmaceutical and biomedical analysis</i> 58 83–93. DOI:<a href=\"https://doi.org/10.1016/j.jpba.2011.09.020\">10.1016/j.jpba.2011.09.020</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/21993198/\">https://pubmed.ncbi.nlm.nih.gov/21993198</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end N06AA17;
